The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy.

Maruf, M; Fascelli, M; George, A K; Siddiqui, M M; Kongnyuy, M; DiBianco, J M; Muthigi, A; Valayil, S; Sidana, A; Frye, T P; Kilchevsky, A; Choyke, P L; Turkbey, B; Wood, B J; Pinto, P A

Maruf, M; Fascelli, M; George, A K; Siddiqui, M M; Kongnyuy, M; DiBianco, J M; Muthigi, A; Valayil, S; Sidana, A; Frye, T P; Kilchevsky, A; Choyke, P L; Turkbey, B; Wood, B J; Pinto, P A.

Affiliation

Maruf M; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Fascelli M; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
George AK; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Siddiqui MM; Division of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Kongnyuy M; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
DiBianco JM; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Muthigi A; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Valayil S; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Sidana A; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Frye TP; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Kilchevsky A; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.
Choyke PL; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Wood BJ; Center for Interventional Oncology, National Cancer Institute & NIH Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Pinto PA; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.

Prostate Cancer Prostatic Dis ; 20(2): 179-185, 2017 06.

Article de En | MEDLINE | ID: mdl-28220802

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Prostate / Tumeurs de la prostate / Cytoponction sous échoendoscopie / Biopsie guidée par l'image Type d'étude: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limites: Aged / Humans / Male / Middle aged Langue: En Journal: Prostate Cancer Prostatic Dis Sujet du journal: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Année: 2017 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google